Yuyu Cao

Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

A multicenter retrospective study of plasma d‑dimer levels for evaluating treatment response in multiple myeloma.

A multicenter retrospective study of plasma d‑dimer levels for evaluating treatment response in multiple myeloma.

Journal: Scientific reports
Published: December 20, 2025

BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer.

BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer.

Journal: Oncogene
Published: March 13, 2025

Mechanisms underlying resistance to CAR-T cell therapy and strategies for enhancement.

Mechanisms underlying resistance to CAR-T cell therapy and strategies for enhancement.

Journal: Cytokine & growth factor reviews
Published: February 15, 2025

DUSP14 suppresses ferroptosis and promotes tumor progression of triple-negative breast cancer.

DUSP14 suppresses ferroptosis and promotes tumor progression of triple-negative breast cancer.

Journal: Cell reports
Published: January 16, 2025

Inner Ear Organoids: A Hydrogel-Based Platform for Drug Screening and Deafness Modeling.

Inner Ear Organoids: A Hydrogel-Based Platform for Drug Screening and Deafness Modeling.

Journal: Neuroscience bulletin
Published: December 27, 2024

Increased ACSL6 Expression Predicts a Favorable Prognosis in Triple-negative Breast Cancer.

Increased ACSL6 Expression Predicts a Favorable Prognosis in Triple-negative Breast Cancer.

Journal: Current medicinal chemistry
Published: September 10, 2023

AS1411-conjugated doxorubicin-loaded silver nanotriangles for targeted chemo-photothermal therapy of breast cancer.

AS1411-conjugated doxorubicin-loaded silver nanotriangles for targeted chemo-photothermal therapy of breast cancer.

Journal: Nanomedicine (London, England)
Published: August 31, 2023

The effect of AS1411 surface density on the tumor targeting properties of PEGylated silver nanotriangles.

The effect of AS1411 surface density on the tumor targeting properties of PEGylated silver nanotriangles.

Journal: Nanomedicine (London, England)
Published: January 21, 2022

AS1411 and EpDT3-conjugated silver nanotriangle-mediated photothermal therapy for breast cancer and cancer stem cells.

AS1411 and EpDT3-conjugated silver nanotriangle-mediated photothermal therapy for breast cancer and cancer stem cells.

Journal: Nanomedicine (London, England)
Published: November 23, 2021

DOX-loaded silver nanotriangles and photothermal therapy exert a synergistic antibreast cancer effect via ROS/ERK1/2 signaling pathway.

DOX-loaded silver nanotriangles and photothermal therapy exert a synergistic antibreast cancer effect via ROS/ERK1/2 signaling pathway.

Journal: Nanotechnology
Published: September 07, 2021

Application of silver nanotriangles as a novel contrast agent in tumor computed tomography imaging.

Application of silver nanotriangles as a novel contrast agent in tumor computed tomography imaging.

Journal: Nanotechnology
Published: April 03, 2021

Increasing the accumulation of aptamer AS1411 and verapamil conjugated silver nanoparticles in tumor cells to enhance the radiosensitivity of glioma.

Increasing the accumulation of aptamer AS1411 and verapamil conjugated silver nanoparticles in tumor cells to enhance the radiosensitivity of glioma.

Journal: Nanotechnology
Published: December 09, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026